Trial Profile
Phase II study of TS-1 + CPT-11 for squamous cell lung cancer previously treated with platinum
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Feb 2020
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Irinotecan (Primary)
- Indications Non-small cell lung cancer; Squamous cell cancer
- Focus Therapeutic Use
- 03 Feb 2020 Status changed from active, no longer recruiting to completed.
- 04 Aug 2011 New trial record